Related Experiment Video
Updated: Mar 16, 2026
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
993
Translating the Science of Psoriasis
1Professor of Dermatology Northwestern University Feinberg School of Medicine Chicago, Illinois.
Seminars in Cutaneous Medicine and Surgery
|August 16, 2016
Summary
Recent discoveries highlight the role of T helper 17 (Th17) cells in psoriasis pathophysiology. Therapies targeting these cells and their associated cytokines, like interleukin-23, are crucial for managing psoriatic inflammation.
Area of Science:
- Immunology
- Dermatology
- Cell Biology
Background:
- Psoriasis pathophysiology understanding has advanced significantly.
- T helper 17 (Th17) cells are key players in psoriatic inflammation.
- Cytokines produced by Th17 cells are implicated in disease mechanisms.
Purpose of the Study:
- To review the evolving knowledge of psoriasis pathophysiology.
- To highlight the role of T helper 17 (Th17) cells and associated cytokines.
- To discuss current and future therapeutic targets within these pathways.
Main Methods:
- Literature review of recent advancements in psoriasis research.
- Analysis of the role of T helper 17 (Th17) cells and cytokines.
- Examination of therapeutic strategies targeting the Th17 pathway.
Main Results:
- Identification of T helper 17 (Th17) cells has reshaped understanding of psoriasis.
- Interleukin-23 (IL-23) promotes differentiation of regulatory T cells into Th17 cells.
- Cytokines from Th17 cells are central to psoriatic inflammation.
Conclusions:
- The Th17 cell pathway is a critical target for psoriasis treatment.
- Interleukin-23 (IL-23) plays a significant role in driving Th17 cell differentiation.
- Novel therapies targeting these pathways offer promise for managing psoriasis.
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
01:22iPS Cell Differentiation
3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
01:20The JAK-STAT Signaling Pathway
13.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.7K
01:24T Cell Types and Functions
3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K
01:19Clinical Applications of Epidermal Stem Cells
3.4K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
3.4K
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
2.3K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
2.3K